### 1. Data Overview

The dataset consists of multiple differential gene expression (DEG) result files derived from a T cell exhaustion time-course experiment, along with a small metadata file describing experimental conditions. Each DEG file contains 36,255 rows, corresponding to genome-wide gene-level measurements, and represents a pairwise comparison between two biological conditions or time points. These files are CSV-formatted tables suitable for downstream bioinformatics analysis.

Specifically, four DEG files capture longitudinal comparisons within the exhausted T cell condition at different late time points relative to day 14 (L14 vs L7, L21 vs L14, L35 vs L14, L60 vs L14), enabling characterization of exhaustion progression. Two additional DEG files compare exhausted (E) versus non-exhausted/less exhausted (L) T cells at early time points (day 5 and day 7), providing contrast between functional and dysfunctional states. The metadata file contains 10 rows describing experimental days, conditions, and categories.

Overall, the data are highly usable for defining a robust T cell exhaustion gene signature, as they provide genome-wide fold changes, statistical significance, and expression abundance (TPM) across multiple biologically relevant contrasts. While no explicit drug-related data are included, the DEG outputs are well suited for integration with external drug–target and drug–transcriptomic databases for drug repositioning analysis.

---

### 2. Column Dictionary (Detailed)

**File: Q5.maryphilip_DEG_L14_group_L14_vs_L7.csv**  
- Unnamed: 0  
  Data Type: string  
  Biological Meaning: Gene identifier (likely gene symbol or Ensembl ID).  
  Usage Recommendation: Use as the primary gene identifier for filtering, ranking, and integration with other DEG files and external databases.  
- log2FoldChange  
  Data Type: numeric  
  Biological Meaning: Log2-transformed fold change of gene expression between L14 and L7 exhausted T cells. Positive values indicate upregulation at L14.  
  Usage Recommendation: Use to determine direction and magnitude of expression changes during exhaustion progression.  
- pvalue  
  Data Type: numeric  
  Biological Meaning: Raw statistical significance of differential expression.  
  Usage Recommendation: Preliminary significance assessment; secondary to adjusted p-values.  
- padj  
  Data Type: numeric  
  Biological Meaning: Multiple-testing adjusted p-value (false discovery rate).  
  Usage Recommendation: Primary criterion for defining significantly differentially expressed genes.  
- meanTPM_L14  
  Data Type: numeric  
  Biological Meaning: Average TPM expression at late day 14.  
  Usage Recommendation: Assess expression abundance and filter low-expression genes.  
- meanTPM_L7  
  Data Type: numeric  
  Biological Meaning: Average TPM expression at late day 7.  
  Usage Recommendation: Contextualize fold changes and confirm biologically meaningful expression.

**File: Q5.maryphilip_DEG_L21_group_L21_vs_L14.csv**  
Columns are analogous to the L14_vs_L7 file, with meanTPM_L21 and meanTPM_L14 representing expression at days 21 and 14, respectively. These columns should be used to track further progression of exhaustion-related transcriptional changes beyond day 14.

**File: Q5.maryphilip_DEG_L35_group_L35_vs_L14.csv**  
Columns mirror the structure above, with meanTPM_L35 and meanTPM_L14. This file supports identification of long-term exhaustion-associated genes maintained or amplified at later stages.

**File: Q5.maryphilip_DEG_L60_group_L60_vs_L14.csv**  
Again, the same column structure applies, with meanTPM_L60 and meanTPM_L14. This file is critical for identifying stable or terminal exhaustion markers at very late time points.

**File: Q5.maryphilip_DEG_day5_group_L5_vs_E5.csv**  
- Unnamed: 0  
  Data Type: string  
  Biological Meaning: Gene identifier.  
  Usage Recommendation: Join key across early exhaustion comparisons.  
- log2FoldChange  
  Data Type: numeric  
  Biological Meaning: Expression difference between L5 (less exhausted) and E5 (exhausted) T cells.  
  Usage Recommendation: Identify early exhaustion drivers and suppressors.  
- pvalue  
  Data Type: numeric  
  Biological Meaning: Raw differential expression p-value.  
  Usage Recommendation: Supporting significance metric.  
- padj  
  Data Type: numeric  
  Biological Meaning: Adjusted p-value for multiple testing.  
  Usage Recommendation: Main threshold for significance.  
- meanTPM_E5  
  Data Type: numeric  
  Biological Meaning: Average expression in exhausted T cells at day 5.  
  Usage Recommendation: Identify genes already dysregulated early in exhaustion.  
- meanTPM_L5  
  Data Type: numeric  
  Biological Meaning: Average expression in less exhausted/functional T cells at day 5.  
  Usage Recommendation: Define baseline effector-like expression patterns.

**File: Q5.maryphilip_DEG_day7_group_L7_vs_E7.csv**  
Structure is identical to the day 5 comparison, with meanTPM_E7 and meanTPM_L7. This file enables validation of early exhaustion signatures across multiple early time points.

**File: Q5.maryphilip_metadata.csv**  
- day  
  Data Type: string  
  Biological Meaning: Experimental time point.  
  Usage Recommendation: Annotate DEG files with temporal context.  
- condition  
  Data Type: string  
  Biological Meaning: Exhausted versus less exhausted condition.  
  Usage Recommendation: Interpret contrasts and group comparisons.  
- category  
  Data Type: string  
  Biological Meaning: Broad experimental grouping.  
  Usage Recommendation: High-level stratification of samples.  
- source  
  Data Type: string  
  Biological Meaning: Origin or reference of samples.  
  Usage Recommendation: Documentation and provenance tracking.

---

### 3. Data Integrity & Quality

All DEG files have consistent row counts (36,255), indicating genome-wide coverage and consistent gene ordering. Gene identifiers appear unique within each file, supporting reliable joins across contrasts. There is no explicit indication of missing values in the summary, but downstream checks for NA values in log2FoldChange or padj are recommended. The “Unnamed: 0” column should be verified to ensure it contains standardized gene identifiers, as inconsistent gene naming could complicate integration with drug databases. Overall statistical quality appears high, as adjusted p-values are provided, enabling rigorous significance filtering.

---

### 4. Sub-Problem Analysis: Data Applicability

**Sub-problem 1: Integrated Strategy for Drug Repositioning to Reverse T Cell Exhaustion**

The primary files needed are all DEG CSV files, particularly the early exhausted vs non-exhausted comparisons (day5 L5_vs_E5 and day7 L7_vs_E7) to define core exhaustion signatures, and the longitudinal late-time comparisons (L14, L21, L35, L60) to identify persistent or terminal exhaustion genes. Key columns are Unnamed: 0 (gene ID), log2FoldChange, and padj. The data are sufficient to define upregulated exhaustion drivers and downregulated effector genes. Recommended filtering includes padj < 0.05 and absolute log2FoldChange thresholds to define robust signatures. These signatures can then be mapped externally to drug–target and drug-induced expression resources, fulfilling the requirements of the sub-problem.

---

### 5. Biological Context (from Data)

The data represent transcriptomic profiles of T cells undergoing exhaustion across multiple time points, likely in a chronic infection or tumor-like setting. Early comparisons (day 5 and 7) contrast exhausted versus functional T cells, capturing initiation of exhaustion. Later comparisons track transcriptional drift from intermediate (day 14) to very late exhaustion (day 60). The organism is implicitly mammalian, most likely mouse, based on time-course design common in murine chronic infection models. The tissue context is T cells, without further subdivision, but the patterns are relevant to CD8+ T cell exhaustion biology.

---

### 6. Recommendations for Solver

**Key Keys**: Use the gene identifier in the “Unnamed: 0” column as the primary join key across all DEG files and for mapping to external drug–gene databases.  
**Pitfalls**: Avoid assuming gene symbols are unique across species or databases without normalization. Do not rely solely on raw p-values; always prioritize padj.  
**Priority**: The most critical step is defining a consistent exhaustion gene signature by intersecting significantly dysregulated genes across early and late time points, as this signature underpins all downstream drug repositioning analyses.

---

### 7. Domain Knowledge Injection

T cell exhaustion is characterized by upregulation of inhibitory receptors such as PDCD1 (PD-1), CTLA4, LAG3, HAVCR2 (TIM-3), and transcription factors like TOX and NR4A family members, alongside downregulation of effector molecules such as IFNG, GZMB, and TNF. Early time points often reflect activation-induced stress and initial inhibitory signaling, whereas late time points capture epigenetically stabilized dysfunction. TPM values represent normalized expression abundance; genes with very low TPM despite significant fold change should be interpreted cautiously. Typical significance thresholds are padj < 0.05 with |log2FoldChange| > 0.5–1.0 for biologically meaningful effects.

---

### 8. Data Integration Strategy (Natural Language - NO CODE)

First, align all DEG files using the gene identifier column to create a unified table where each gene has fold changes and significance values across all comparisons. Early exhaustion signatures should be derived by selecting genes consistently upregulated in E versus L at days 5 and 7, while late exhaustion maintenance genes should be those persistently dysregulated from day 14 through day 60. Mismatches in gene identifiers across files should be resolved by filtering to the intersection set present in all files. After integration, the expected row count will remain close to 36,255 genes, with some reduction if filtering for significance or consistency is applied.

---

### 9. Step-by-Step Analysis Workflow (Natural Language - NO CODE)

Step 1 involves loading all DEG and metadata files and validating gene identifiers and statistical columns.  
Step 2 defines early T cell exhaustion signatures by filtering day 5 and day 7 comparisons for significantly upregulated and downregulated genes in exhausted cells.  
Step 3 characterizes exhaustion progression by examining longitudinal DEG files to identify genes whose dysregulation persists or intensifies over time.  
Step 4 consolidates these results into a core exhaustion gene signature, separating upregulated inhibitory/metabolic regulators from downregulated effector/memory genes.  
Step 5 integrates this signature with external drug–target and drug-induced transcriptomic databases to score drugs based on their ability to reverse the exhaustion signature.  
Step 6 prioritizes candidate drugs using reversal strength, relevance of targets to T cell biology, and clinical development status.  
The final step combines ranked drug candidates with mechanistic hypotheses linking drug targets to known exhaustion pathways, while performing quality checks such as signature robustness and biological plausibility.